Clinical Trial Update: Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)

View source ↗

Summary

Expanded-access multicenter study of Lucanix (Belagenpumatucel-L) for non-small cell lung cancer is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Lucanix

Snippet

Sponsor: NovaRx Corporation | Conditions: Non-small Cell Lung Cancer | Status: NO_LONGER_AVAILABLE